Literature DB >> 16641473

Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants.

P Littauer1, D A Caugant, M Sangvik, E A Høiby, A Sundsfjord, G S Simonsen.   

Abstract

A 2.7% prevalence of macrolide resistance in 1,657 Norwegian clinical Streptococcus pyogenes isolates was primarily due to erm(TR) (59%) and mef(A) (20%). Four clonal complexes comprised 75% of the strains. Macrolide resistance in S. pyogenes in Norway is imported as resistant strains or locally selected in internationally disseminated susceptible clones.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16641473      PMCID： PMC1472204          DOI： 10.1128/AAC.50.5.1896-1899.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  39 in total

1.  Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.

Authors:  Maria P Montanari; Ileana Cochetti; Marina Mingoia; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

2.  A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes.

Authors:  Eleonora Giovanetti; Andrea Brenciani; Roberto Burioni; Pietro Emanuele Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates.

Authors:  Melissa M Daly; Stella Doktor; Robert Flamm; Dee Shortridge
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Genetic and phenotypic characterization of resistance to macrolides in Streptococcus pyogenes from Argentina.

Authors:  Silvia Martínez; Ana M Amoroso; Angela Famiglietti; Carmen de Mier; Carlos Vay; Gabriel O Gutkind
Journal:  Int J Antimicrob Agents       Date:  2004-01       Impact factor: 5.283

5.  Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures.

Authors:  Karen F McGregor; Brian G Spratt; Awdhesh Kalia; Alicia Bennett; Nicole Bilek; Bernard Beall; Debra E Bessen
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

6.  Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.

Authors:  Ralf René Reinert; Carmen Franken; Mark van der Linden; Rudolf Lütticken; Murat Cil; Adnan Al-Lahham
Journal:  Int J Antimicrob Agents       Date:  2004-07       Impact factor: 5.283

7.  Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.

Authors:  Miika Bergman; Solja Huikko; Marja Pihlajamäki; Pekka Laippala; Erkki Palva; Pentti Huovinen; Helena Seppälä
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

8.  Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.

Authors:  J I Alós; B Aracil; J Oteo; J L Gómez-Garcés
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

9.  Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany.

Authors:  Ralf R Reinert; Rudolf Lütticken; Joyce A Sutcliffe; Amelia Tait-Kamradt; Murat Y Cil; Holger M Schorn; André Bryskier; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes.

Authors:  Werner C Albrich; Dominique L Monnet; Stephan Harbarth
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883
View more
  12 in total

1.  Clonal spread of macrolide- and tetracycline-resistant [erm(A) tet(O)] emm77 Streptococcus pyogenes isolates in Italy and Norway.

Authors:  Claudio Palmieri; Manuela Vecchi; Pia Littauer; Arnfinn Sundsfjord; Pietro E Varaldo; Bruna Facinelli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

2.  Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area.

Authors:  R Pires; D Rolo; A Morais; A Brito-Avô; C Johansson; B Henriques-Normark; J Gonçalo-Marques; I Santos-Sanches
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-21       Impact factor: 3.267

3.  Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.

Authors:  Devrim Dundar; Murat Sayan; Gulden Sonmez Tamer
Journal:  Microb Drug Resist       Date:  2010-07-12       Impact factor: 3.431

4.  Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.

Authors:  Alberto Villaseñor-Sierra; Eva Katahira; Abril N Jaramillo-Valdivia; María de los Angeles Barajas-García; Amy Bryant; Rayo Morfín-Otero; Francisco Márquez-Díaz; Juan Carlos Tinoco; José Sánchez-Corona; Dennis L Stevens
Journal:  Int J Infect Dis       Date:  2012-01-02       Impact factor: 3.623

Review 5.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

Review 6.  Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.

Authors:  Markus Zeitlinger; Claudia Christina Wagner; Birgit Heinisch
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

7.  Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003.

Authors:  Roger Meisal; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

8.  Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.

Authors:  Roger Meisal; Ida K G Andreasson; E Arne Høiby; Ingeborg S Aaberge; Terje E Michaelsen; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

9.  Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).

Authors:  Virginia Rubio-López; Sylvia Valdezate; David Alvarez; Pilar Villalón; María José Medina; Celia Salcedo; Juan-Antonio Sáez-Nieto
Journal:  BMC Microbiol       Date:  2012-09-21       Impact factor: 3.605

10.  Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium.

Authors:  Liesbet Van Heirstraeten; Samuel Coenen; Christine Lammens; Niel Hens; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.